FACE IPF
HEAD ON
and modify disease progression by slowing lung function decline
OFEV®(nintedanib) is a Recommended Treatment Option at Diagnosis for SSc-ILD Patients If Pharmacological Treatment is Required
Related Product Item
PPF Diagnosis and Treatment in the Respiratory (ATS/ERS/JRS/ALAT) Guideline
PC-IME-100565 (
)
Risk score for RA-ILD Patient
PC-IME-100562 (
)
Risk score for RA-ILD Patients
PC-IME-100561 (
)
